Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes
- 1 November 1980
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 4 (4), 267-269
- https://doi.org/10.1007/bf00255272
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapyCancer Chemotherapy and Pharmacology, 1979
- High Dose Medroxyprogesterone Acetate (MPA) Treatment in Metastatic Carcinoma of the Breast: A Dose-Response EvaluationTumori Journal, 1978
- POSSIBLE NEW APPROACH TO TREATMENT OF METASTATIC BREAST-CANCER - MASSIVE DOSES OF MEDROXYPROGESTERONE ACETATE1978
- High Dose Medroxyprogesterone-Acetate Treatment in Advanced Mammary Carcinoma: A Phase II InvestigationActa Radiologica: Oncology, Radiation, Physics, Biology, 1978
- RESPONSE TO MEDROXYPROGESTERONE ACETATE (NSC-26386) AS SECONDARY HORMONE THERAPY FOR METASTATIC BREAST-CANCER IN POSTMENOPAUSAL WOMEN1976
- RADIOIMMUNOASSAY OF OESTRONE AND OESTRADIOL IN HUMAN AND BOVINE PERIPHERAL PLASMAActa Endocrinologica, 1972
- Measurement of Medroxyprogesterone Acetate (Provera) by Radioimmunoassay1Journal of Clinical Endocrinology & Metabolism, 1971
- Treatment of Breast Cancer with Medroxyprogesterone AcetateAnnals of Internal Medicine, 1968
- Hormonal therapy in cancer of the breast.XXIV. Effect of corticosterone or medroxyprogesterone acetate on clinical course and hormonal excretionCancer, 1967
- Progestin therapy of breast cancer: comparison of agents.BMJ, 1967